lingo.lol is one of the many independent Mastodon servers you can use to participate in the fediverse.
A place for linguists, philologists, and other lovers of languages.

Server stats:

60
active users

#epidemiology

0 posts0 participants0 posts today
Unpatentable.org<p>Swarm intelligence protocol transforms epidemic modeling. Autonomous agents communicate peer-to-peer, integrating bioinformatics data and blockchain consensus. Democratizes outbreak forecasting for resource-constrained organizations. Invented by Unpatentable AI.</p><p><a href="https://mastodon.social/tags/OpenScience" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenScience</span></a> <a href="https://mastodon.social/tags/PublicHealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PublicHealth</span></a> <a href="https://mastodon.social/tags/Epidemiology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Epidemiology</span></a></p><p>Full Report: <a href="https://unpatentable.org/innovation/decentralized-swarm-intelligence-protocol-for-open-source-epidemic-modeling-via-bioinformatics-integrated-agent-networks/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">unpatentable.org/innovation/de</span><span class="invisible">centralized-swarm-intelligence-protocol-for-open-source-epidemic-modeling-via-bioinformatics-integrated-agent-networks/</span></a></p>
jobRxiv<p>Post-Doctoral Research Fellow - Leek Lab<br>Fred Hutchinson Cancer Center </p><p>See the full job description on jobRxiv: <a href="https://jobrxiv.org/job/fred-hutchinson-cancer-center-27778-post-doctoral-research-fellow-leek-lab/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">jobrxiv.org/job/fred-hutchinso</span><span class="invisible">n-cancer-center-27778-post-doctoral-research-fellow-leek-lab/</span></a></p><p><a href="https://mas.to/tags/biostatistics" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>biostatistics</span></a> <a href="https://mas.to/tags/cancergenomics" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>cancergenomics</span></a> <a href="https://mas.to/tags/epidemiology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>epidemiology</span></a> <a href="https://mas.to/tags/oncology" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>oncology</span></a> <a href="https://mas.to/tags/postdoctoral" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>postdoctoral</span></a> <a href="https://mas.to/tags/ScienceJobs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ScienceJobs</span></a> <a href="https://mas.to/tags/hiring" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>hiring</span></a> <a href="https://mas.to/tags/research" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>research</span></a><br><a href="https://jobrxiv.org/job/fred-hutchinson-cancer-center-27778-post-doctoral-research-fellow-leek-lab/?fsp_sid=3896" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">jobrxiv.org/job/fred-hutchinso</span><span class="invisible">n-cancer-center-27778-post-doctoral-research-fellow-leek-lab/?fsp_sid=3896</span></a></p>

🌡️ **Over 60,000 Europeans died from heat during 2024 summer: study**

"_According to the study, Italy was the country with the most heat deaths last summer with an estimated 19,000, followed by Spain and Germany, both with over 6,000._"

🔗 france24.com/en/live-news/2025

FRANCE 24 · Over 60,000 Europeans died from heat during 2024 summer: studyBy France 24

(🧵1 /13) The fascinating history of pellagra.

Pellagra symptoms include a skin rash, mouth sores, diarrhea, dementia, and ultimately death. It spread throughout Europe in the 18th and 19th centuries, typically in poor regions where corn was the staple, and in institutions (prisons, orphanages, and asylums). 

This thread compares the relative ease of eliminating pellagra in France in the 19th century, versus the uphill battle faced by epidemiologists in the US in the 20th century.

Hey Mastodon, a little late at this point but a #introduction post! I'm a mathematician working in #epidemiology who loves learning about new subfields and application areas.

Math hobbies/interests: #relativity #cryptography #dynamical_systems #cybersecurity

Passionate about digital #privacy , #climate , other #activism and want to get more involved on those issues

Fandoms: #stargate #startrek

Also want to find out more about e-bikes, so if you have recommendations let me know!

Sen. Cassidy finally grew a pair!

“Although the appointees to [the Advisory Committee for Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, #epidemiology or #immunology. In particular, some lack experience studying new technologies such as #mRNA #vaccines, and may even have a preconceived bias against them,” Sen. Bill Cassidy (R-La.) wrote on the social media site X Monday evening. (paywalled)

statnews.com/2025/06/23/bill-c

STAT · Cassidy calls to delay meeting of CDC's vaccine panel in challenge to RFK Jr.A key GOP senator is calling for the CDC's vaccine meeting to be postponed after RFK Jr. shook up the panel.
Replied in thread

Wear a respirator or good quality face mask. Yes, you can develop Long Covid.
Yes, you are at risk of infecting other people.
Yes, you may host the next new coronavirus variant.
You are not magic, but you have people around you who care about you.
You interact with other people who have others who care about them.

Act like the responsible person you want to believe you are.
Mask up, don a respirator, or pretend you're a secret agent, astronaut, cosmonaut, laboratory scientist or whatever else.

Reduce your health hazards to living beings around you.
(Cats and dogs can get covid too.
Filtered air reduces infections for colds, influenza viruses, and other pathogens.)

Me when outside or talking to anyone: lgbtqia.space/@nat@kind.social

lgbtqia.spaceLGBTQIA.Space

'Epidemiological changes in Toxoplasma infection: a 7-year longitudinal study in pregnant women in Lyon, France, 2017–2023
Translated title: Évolution épidémiologique de l’infection à Toxoplasma : étude longitudinale sur 7 ans chez les femmes enceintes à Lyon (2017-2023)'

- an article in 'Parasite' by @EDPSciences on #ScienceOpen:

🔗 scienceopen.com/document?vid=0

ScienceOpenEpidemiological changes in <i>Toxoplasma</i> infection: a 7-year longitudinal study in pregnant women in Lyon, France, 2017–2023 <span class="so-article-trans-title" dir="auto"> Translated title: Évolution épidémiologique de l’infection à <i>Toxoplasma</i> : étude longitudinale sur 7 ans chez les femmes enceintes à Lyon (2017-2023) </span><p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d4166648e332">The epidemiology of <i>Toxoplasma</i> infection is known to vary geographically, but is also likely to vary over time, under the influence of many contributing factors. Monitoring is particularly useful in the context of preventing congenital toxoplasmosis. We took advantage of the French prenatal prevention programme to retrospectively assess changes between 2017 and 2023 in seroprevalence and incidence rates of <i>Toxoplasma</i> infection in pregnant women and the incidence of congenital infections. We conducted a longitudinal retrospective study including all pregnancies with known <i>Toxoplasma</i> status followed up at Lyon’s public maternity hospitals between 2017 and 2023 (71,922 pregnancies). We used a multivariable logistic regression model to identify factors (age-group, WHO region of origin, population density of the area of residence and parity) associated with seropositivity. The seroprevalence of toxoplasmosis decreased consistently from 26.4% in 2017 to 22.1% in 2023 ( <i>p</i> = 0.003), while maternal infection incidence remained stable at 1.3/1,000 pregnancies at risk. Notably, the seroprevalence showed a linear increase with age from 18.9% in women aged 25–29 years to 38.0% in women aged ≥40 years ( <i>p</i> < 0.001). The seroprevalence was lower in pregnant women living in rural areas [adjusted seroprevalence ratio (aPR) = 0.87, 95% CI: 0.82–0.92] and higher in multiparous women (aPR = 1.08, 95% CI: 1.04–1.12). This study confirms the ongoing decline in toxoplasmosis seroprevalence while seroconversions remained stable, indicating a need for more tests in seronegative women in the future. These findings highlight the need for ongoing monitoring and refinement of congenital toxoplasmosis prevention strategies in high-income countries. </p><p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d4166648e350">Il est connu que l’épidémiologie de l’infection à <i>Toxoplasma</i> varie selon les zones géographiques, mais elle est également susceptible de varier au fil du temps, sous l’influence de nombreux facteurs contributifs. La surveillance est particulièrement utile dans le cadre de la prévention de la toxoplasmose congénitale. Nous avons exploité le programme français de prévention prénatale pour évaluer rétrospectivement l’évolution entre 2017 et 2023 de la séroprévalence et des taux d’incidence de l’infection à <i>Toxoplasma</i> chez les femmes enceintes, ainsi que de l’incidence des infections congénitales. Nous avons mené une étude rétrospective longitudinale incluant toutes les grossesses dont le statut toxoplasmique était connu, suivies dans les maternités publiques de Lyon entre 2017 et 2023 (71 922 grossesses). Nous avons utilisé un modèle de régression logistique multivariée pour identifier les facteurs (tranche d’âge, région d’origine OMS, densité de population du lieu de résidence et parité) associés à la séropositivité. La séroprévalence de la toxoplasmose a diminué de façon constante, passant de 26,4 % en 2017 à 22,1 % en 2023 ( <i>p</i> = 0,003), tandis que l’incidence de l’infection maternelle est restée stable à 1,3/1 000 grossesses à risque. Il est à noter que la séroprévalence a montré une augmentation linéaire avec l’âge, passant de 18,9 % chez les femmes âgées de 25 à 29 ans à 38,0 % chez les femmes âgées de plus de 40 ans ( <i>p</i> < 0,001). La séroprévalence était plus faible chez les femmes enceintes vivant en zone rurale [rapport de séroprévalence ajusté (aPR) = 0,87, IC à 95 % : 0,82-0,92] et plus élevée chez les femmes multipares (aPR = 1,08, IC à 95 % : 1,04-1,12). Cette étude confirme la baisse continue de la séroprévalence de la toxoplasmose, tandis que les séroconversions sont restées stables, ce qui indique la nécessité de réaliser davantage de tests chez les femmes séronégatives à l’avenir. Ces résultats soulignent la nécessité d’une surveillance continue et d’un perfectionnement des stratégies de prévention de la toxoplasmose congénitale dans les pays à revenu élevé. </p>